Dataset from A 52-week Treatment, Multi-center, Randomized, Double-blind, Double Dummy, Parallel-group, Active Controlled Study to Compare the Effect of QVA149 (Indacaterol Maleate / Glycopyrronium Bromide) With Salmeterol/Fluticasone on the Rate of Exacerbations in Subjects With Moderate to Very Severe COPD. (FLAME).
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00012421
下载链接
链接失效反馈官方服务：
资源简介：
This study will assess the efficacy, safety and tolerability of QVA149 in patients with moderate to very severe COPD.
创建时间：
2025-12-16
